Dramatic response after functional hemispherectomy in a patient with epileptic encephalopathy carrying a de novo COL4A1 mutation

被引:8
|
作者
Hino-Fukuyo, Naomi [1 ,2 ]
Kikuchi, Atsuo [2 ]
Iwasaki, Masaki [3 ]
Sato, Yuko [2 ]
Kubota, Yuki [2 ]
Kobayashi, Tomoko [2 ]
Nakayama, Tojo [2 ]
Haginoya, Kazuhiro [2 ,4 ]
Arai-Ichinoi, Natsuko [2 ]
Niihori, Tetsuya [1 ,5 ]
Sato, Ryo [2 ]
Suzuki, Tasuku [2 ]
Kudo, Hiroki [2 ]
Funayama, Ryo [6 ]
Nakayama, Keiko [6 ]
Aoki, Yoko [1 ,5 ]
Kure, Shigeo [2 ]
机构
[1] Tohoku Univ Hosp, Ctr Genom Med, Sendai, Miyagi, Japan
[2] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi, Japan
[3] Natl Ctr Hosp Neurol & Psychiat, Dept Neurosurg, Kodaira, Tokyo, Japan
[4] Miyagi Childrens Hosp, Dept Neurol, Sendai, Miyagi, Japan
[5] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan
[6] Tohoku Univ, Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Miyagi, Japan
来源
BRAIN & DEVELOPMENT | 2017年 / 39卷 / 04期
基金
日本学术振兴会;
关键词
COL4A1; Epileptic encephalopathy; Hemiplegia; Porencephaly; Infantile spasms; Functional hemispherectomy; COL4A1; MUTATIONS; HEMORRHAGE;
D O I
10.1016/j.braindev.2016.11.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe the first case of a successful functional hemispherectomy in a patient with epileptic encephalopathy and a de novo collagen type IV alpha 1 (COL4A1) mutation. A 4-year-old girl was COL4A1 mutation-positive and suffered from drug-resistant epilepsy, hemiplegia, and developmental delay. Magnetic resonance imaging detected no porencephaly, and she had no cataract or renal abnormality. Following a presurgical evaluation for epilepsy, she underwent a functional hemispherectomy. She has been seizure free with no intracranial hemorrhage or other perioperative complications. Patients with a COL4A1 mutation have an increased risk for intracranial hemorrhage because of disrupted integrity in the vascular basement membrane due to the mutation. After weighing the risks and benefits to these patients, epilepsy surgery may not be absolutely contraindicated. Furthermore, pediatric neurologists should be aware of an undiagnosed COL4A1 mutation when a patient presents with an unexplained neurological phenotype, such as mild hemiparesis, even in the absence of porencephaly. (C) 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [41] From normal development after prematurity to end of life within 11 months: Early infantile epileptic encephalopathy with migrating seizures due to de novo KCNT1 mutation
    Niermeijer, J. M.
    Van Bavel-Ta, V.
    Jansen, F. E.
    Remmers, A.
    EPILEPSIA, 2024, 65 : 389 - 389
  • [42] A de novo COL17A1 splicesite mutation causing a 7-bp deletion in a Taiwanese patient with junctional epidermolysis bullosa
    Ping-Chen Hou
    Wei-Ting Tu
    Peng-Chieh Chen
    Bryan Edgar K. Guevara
    Yu-Fen Yen
    Hsin-Yu Huang
    Julia Yu-Yun Lee
    Ming-Jer Tang
    Pao-Lin Kuo
    John A. McGrath
    Chao-Kai Hsu
    European Journal of Dermatology, 2021, 31 : 267 - 269
  • [43] Trio whole-exome sequencing reveals a novel de novo mutation in COL2A1 gene in an Iranian patient with hypochondroplasia
    Azam, Fatemeh Karimi
    Sohrabi, Behnoush
    Rahimi, Hamzeh
    Ganji, Maziar
    GENE REPORTS, 2023, 31
  • [44] A de novo COL17A1 splicesite mutation causing a 7-bp deletion in a Taiwanese patient with junctional epidermolysis bullosa
    Hou, Ping-Chen
    Tu, Wei-Ting
    Chen, Peng-Chieh
    Guevara, Bryan Edgar K.
    Yen, Yu-Fen
    Huang, Hsin-Yu
    Lee, Julia Yu-Yun
    Tang, Ming-Jer
    Kuo, Pao-Lin
    McGrath, John A.
    Hsu, Chao-Kai
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (02) : 267 - 269
  • [45] A de novo loss-of-function DYNC1H1 mutation in a patient with parkinsonian features and a favourable response to levodopa
    Szczaluba, K.
    Szymanska, K.
    Rydzanicz, M.
    Ciara, E.
    Walczak, A.
    Piekutowska-Abramczuk, D.
    Kosinska, J.
    Jacoszek, A.
    Czerska, K.
    Biernacka, A.
    Laure-Kamionowska, M.
    Gasperowicz, P.
    Pronicka, E.
    Ploski, R.
    CLINICAL GENETICS, 2018, 93 (05) : 1107 - 1108
  • [46] Generation of iPSC lines (KAUSTi011-A, KAUSTi011-B) from a Saudi patient with epileptic encephalopathy carrying homozygous mutation in the GLP1R gene
    Alowaysi, Maryam
    Astro, Veronica
    Fiacco, Elisabetta
    Alzahrani, Fatema
    Alkuraya, Fowzan S.
    Adamo, Antonio
    STEM CELL RESEARCH, 2021, 50
  • [47] Establishment of an induced pluripotent stem cell line (ZJS']JSHi001-A) from a patient with epileptic encephalopathy carrying KCNB1 Glu330Asp mutation
    Guo, Yufan
    Wang, Jianda
    Wang, ZhiLiang
    Lou, Yuting
    Chen, Wangyang
    Sheng, Min
    Wang, Ye
    Zhang, Bijun
    Gao, Liuyan
    Feng, Jianhua
    STEM CELL RESEARCH, 2021, 52
  • [48] Early Involvement of the Corpus Callosum in a Patient with Hereditary Diffuse Leukoencephalopathy with Spheroids Carrying the de novo K793T Mutation of CSF1R
    Kondo, Yasufumi
    Kinoshita, Michiaki
    Fukushima, Kazuhiro
    Yoshida, Kunihiro
    Ikeda, Shu-ichi
    INTERNAL MEDICINE, 2013, 52 (04) : 503 - 506
  • [49] Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up
    Dicanio, Daniela
    Nicotera, Antonio Gennaro
    Cucinotta, F.
    Di Rosa, G.
    NEUROLOGICAL SCIENCES, 2021, 42 (04) : 1627 - 1629
  • [50] Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders
    Chen, Wenlin
    Ge, Yang
    Lu, Jie
    Melo, Joshua
    So, Yee Wah
    Juneja, Romi
    Liu, Lidong
    Wang, Yu Tian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)